Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Syndax Pharma (SNDX)

Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon BayStreet.ca - Thu Nov 14, 8:45AM CST

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll...

ONCY : 0.9541 (-2.64%)
IOVA : 8.55 (+3.76%)
SNDX : 16.09 (+3.14%)
ONC.TO : 1.33 (-2.92%)
IBRX : 5.10 (+1.29%)
SWTX : 39.02 (+7.49%)
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon Newswire.ca - Thu Nov 14, 7:00AM CST

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

ONCY : 0.9541 (-2.64%)
IOVA : 8.55 (+3.76%)
SNDX : 16.09 (+3.14%)
ONC.TO : 1.33 (-2.92%)
IBRX : 5.10 (+1.29%)
SWTX : 39.02 (+7.49%)
Syndax: Q3 Earnings Snapshot AP - Tue Nov 5, 3:09PM CST

Syndax: Q3 Earnings Snapshot

SNDX : 16.09 (+3.14%)
Syndax: Q2 Earnings Snapshot AP - Thu Aug 1, 3:46PM CDT

Syndax: Q2 Earnings Snapshot

SNDX : 16.09 (+3.14%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies FinancialNewsMedia - Mon Jun 17, 8:00AM CDT

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END

SNDX : 16.09 (+3.14%)
ATNM : 1.4500 (-1.36%)
KURA : 10.80 (+7.36%)
BMEA : 6.44 (+0.94%)
JNJ : 155.17 (-0.21%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies GlobeNewswire - Mon Jun 17, 8:00AM CDT

SNDX : 16.09 (+3.14%)
ATNM : 1.4500 (-1.36%)
KURA : 10.80 (+7.36%)
BMEA : 6.44 (+0.94%)
JNJ : 155.17 (-0.21%)
Syndax: Q1 Earnings Snapshot AP - Wed May 8, 6:27AM CDT

Syndax: Q1 Earnings Snapshot

SNDX : 16.09 (+3.14%)
Syndax: Q4 Earnings Snapshot AP - Tue Feb 27, 3:48PM CST

Syndax: Q4 Earnings Snapshot

SNDX : 16.09 (+3.14%)
Syndax: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Syndax: Q3 Earnings Snapshot

SNDX : 16.09 (+3.14%)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Oct 6, 2023

/PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today...

SNDX : 16.09 (+3.14%)

Barchart Exclusives

Is It Safe to Buy Super Micro Computer Stock? Barchart - 22 minutes ago
SMCI stock had a great week, but the stock hasn't resolved all of its issues yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot